|
ZNF572 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.61759999994793E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65795000000024E-05 |
| Normal-vs-Stage2 |
1.171540E-04 |
| Normal-vs-Stage3 |
8.21700000042114E-07 |
| Normal-vs-Stage4 |
6.68080000210125E-08 |
| Stage1-vs-Stage2 |
8.653600E-01 |
| Stage1-vs-Stage3 |
1.531000E-01 |
| Stage1-vs-Stage4 |
1.723800E-02 |
| Stage2-vs-Stage3 |
2.592000E-01 |
| Stage2-vs-Stage4 |
3.656200E-02 |
| Stage3-vs-Stage4 |
2.291800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.06050000003854E-06 |
| Normal-vs-AfricanAmerican |
8.296200E-03 |
| Normal-vs-Asian |
2.30259999999261E-05 |
| Caucasian-vs-AfricanAmerican |
3.380200E-01 |
| Caucasian-vs-Asian |
6.516800E-01 |
| AfricanAmerican-vs-Asian |
6.248800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.74040000000742E-05 |
| Normal-vs-Female |
9.7584000002815E-07 |
| Male-vs-Female |
2.091400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.58666999999779E-05 |
| Normal-vs-Age(41-60Yrs) |
7.75620000004196E-07 |
| Normal-vs-Age(61-80Yrs) |
5.73889999999633E-05 |
| Normal-vs-Age(81-100Yrs) |
5.658000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.939200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.718200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.752000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.800150E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.623800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.572030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.610200E-02 |
| Classical-VS-Follicular |
1.795160E-01 |
| Classical-VS-Other |
4.295400E-01 |
| Classical-VS-Normal |
2.634600000051E-06 |
| Tall-VS-Follicular |
5.078200E-03 |
| Tall-VS-Other |
2.474400E-01 |
| Tall-VS-Normal |
8.22329999650151E-08 |
| Follicular-VS-Other |
8.418800E-01 |
| Follicular-VS-Normal |
2.995000E-04 |
| Other-VS-Normal |
1.527350E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.52550000000118E-05 |
| Normal-vs-N1 |
3.97689999820372E-08 |
| N0-vs-N1 |
2.222300E-03 |
|
|
